Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders

Yan Cai,1 Seong Soo A An,1 SangYun Kim2 1Department of Bionano Technology, Gachon Medical Research Institute, Gachon University, 2Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea Abstract: Alzh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cai Y, An SSA, Kim SY
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/40b9f8b4c33540fbae3385fd083e204a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:40b9f8b4c33540fbae3385fd083e204a
record_format dspace
spelling oai:doaj.org-article:40b9f8b4c33540fbae3385fd083e204a2021-12-02T06:55:27ZMutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders1178-1998https://doaj.org/article/40b9f8b4c33540fbae3385fd083e204a2015-07-01T00:00:00Zhttps://www.dovepress.com/mutations-in-presenilin-2-and-its-implications-in-alzheimerrsquos-dise-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Yan Cai,1 Seong Soo A An,1 SangYun Kim2 1Department of Bionano Technology, Gachon Medical Research Institute, Gachon University, 2Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea Abstract: Alzheimer’s disease (AD) is the most common form of dementia. Mutations in the genes encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have been identified as the main genetic causes of familial AD. To date, more than 200 mutations have been described worldwide in PSEN1, which is highly homologous with PSEN2, while mutations in PSEN2 have been rarely reported. We performed a systematic review of studies describing the mutations identified in PSEN2. Most PSEN2 mutations were detected in European and in African populations. Only two were found in Korean populations. Interestingly, PSEN2 mutations appeared not only in AD patients but also in patients with other disorders, including frontotemporal dementia, dementia with Lewy bodies, breast cancer, dilated cardiomyopathy, and Parkinson’s disease with dementia. Here, we have summarized the PSEN2 mutations and the potential implications of these mutations in dementia-associated disorders. Keywords: mutations in presenilin 2, Alzheimer’s diseaseCai YAn SSAKim SYDove Medical Pressarticlepresenilin 2mutationAlzheimer's diseaseGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 1163-1172 (2015)
institution DOAJ
collection DOAJ
language EN
topic presenilin 2
mutation
Alzheimer's disease
Geriatrics
RC952-954.6
spellingShingle presenilin 2
mutation
Alzheimer's disease
Geriatrics
RC952-954.6
Cai Y
An SSA
Kim SY
Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
description Yan Cai,1 Seong Soo A An,1 SangYun Kim2 1Department of Bionano Technology, Gachon Medical Research Institute, Gachon University, 2Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea Abstract: Alzheimer’s disease (AD) is the most common form of dementia. Mutations in the genes encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have been identified as the main genetic causes of familial AD. To date, more than 200 mutations have been described worldwide in PSEN1, which is highly homologous with PSEN2, while mutations in PSEN2 have been rarely reported. We performed a systematic review of studies describing the mutations identified in PSEN2. Most PSEN2 mutations were detected in European and in African populations. Only two were found in Korean populations. Interestingly, PSEN2 mutations appeared not only in AD patients but also in patients with other disorders, including frontotemporal dementia, dementia with Lewy bodies, breast cancer, dilated cardiomyopathy, and Parkinson’s disease with dementia. Here, we have summarized the PSEN2 mutations and the potential implications of these mutations in dementia-associated disorders. Keywords: mutations in presenilin 2, Alzheimer’s disease
format article
author Cai Y
An SSA
Kim SY
author_facet Cai Y
An SSA
Kim SY
author_sort Cai Y
title Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_short Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_full Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_fullStr Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_full_unstemmed Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_sort mutations in presenilin 2 and its implications in alzheimer’s disease and other dementia-associated disorders
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/40b9f8b4c33540fbae3385fd083e204a
work_keys_str_mv AT caiy mutationsinpresenilin2anditsimplicationsinalzheimerrsquosdiseaseandotherdementiaassociateddisorders
AT anssa mutationsinpresenilin2anditsimplicationsinalzheimerrsquosdiseaseandotherdementiaassociateddisorders
AT kimsy mutationsinpresenilin2anditsimplicationsinalzheimerrsquosdiseaseandotherdementiaassociateddisorders
_version_ 1718399686765707264